Search research articles
Contact Us
Filters
Showing results (1291-1300 of 1,511) with videos related to
Page
of 152
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 24, 2018
Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era
David S Lynch, Charles Wade, Anderson Rodrigues Brandão de Paiva, et al.
Brain : a Journal of Neurology
|
March 30, 2013
Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease
Natalie S Ryan, Shiva Keihaninejad, Timothy J Shakespeare, et al.
Journal of the American College of Cardiology
|
March 20, 2019
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Daniel P Judge, Stephen B Heitner, Rodney H Falk, et al.
Journal of Neurology
|
February 3, 2018
Primary progressive aphasia: a clinical approach
Charles R Marshall, Chris J D Hardy, Anna Volkmer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
October 1, 2020
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
Ashvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 19, 2026
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PET
Ashvini Keshavan, Katharine Wiltshire, Ryan Wee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 31, 2016
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
Ross W Paterson, Jamie Toombs, Miles D Chapman, et al.
The Lancet. Neurology
|
March 2, 2010
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O Rinne, David J Brooks, Martin N Rossor, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 24, 2017
The clinical, neuroanatomical, and neuropathologic phenotype of <i>TBK1</i>-associated frontotemporal dementia: A longitudinal case report
Carolin A M Koriath, Martina Bocchetta, Emilie Brotherhood, et al.
Neurobiology of Aging
|
September 4, 2013
Validation of next-generation sequencing technologies in genetic diagnosis of dementia
John Beck, Alan Pittman, Gary Adamson, et al.
Page
of 152
Search research articles
Search
Showing results (1291-1300 of 1,511) with videos related to
Sort By:
Page
of 152
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 24, 2018
Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era
David S Lynch, Charles Wade, Anderson Rodrigues Brandão de Paiva, et al.
Brain : a Journal of Neurology
|
March 30, 2013
Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease
Natalie S Ryan, Shiva Keihaninejad, Timothy J Shakespeare, et al.
Journal of the American College of Cardiology
|
March 20, 2019
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Daniel P Judge, Stephen B Heitner, Rodney H Falk, et al.
Journal of Neurology
|
February 3, 2018
Primary progressive aphasia: a clinical approach
Charles R Marshall, Chris J D Hardy, Anna Volkmer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
October 1, 2020
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
Ashvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 19, 2026
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PET
Ashvini Keshavan, Katharine Wiltshire, Ryan Wee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 31, 2016
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
Ross W Paterson, Jamie Toombs, Miles D Chapman, et al.
The Lancet. Neurology
|
March 2, 2010
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O Rinne, David J Brooks, Martin N Rossor, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 24, 2017
The clinical, neuroanatomical, and neuropathologic phenotype of <i>TBK1</i>-associated frontotemporal dementia: A longitudinal case report
Carolin A M Koriath, Martina Bocchetta, Emilie Brotherhood, et al.
Neurobiology of Aging
|
September 4, 2013
Validation of next-generation sequencing technologies in genetic diagnosis of dementia
John Beck, Alan Pittman, Gary Adamson, et al.
Page
of 152